Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: Results from the ClearWay™ Multicenter Registry-Reference-Cited by-同舟云学术

Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: Results from the ClearWay™ Multicenter Registry

Published:2013-09 Issue:5 Volume:14 Page:280-283
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Maluenda Gabriel,Sizemore Byron C.,Revtyak George,Cavros Nick,McElroy Bradley B.,Arora Dilip S.,Deibele Al,Makam Satyaprakash,Ben-Dor Itsik,Torguson Rebecca,Waksman Ron

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference20 articles.

1. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention;Singh;J Am Coll Cardiol,2002

2. Predictors and time-related impact of distal embolization during primary angioplasty;Napodano;Eur Heart J,2009

3. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study;Vlaar;Lancet,2008

4. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis;Collet;Arterioscler Thromb Vasc Biol,2001

5. Successful dissolution of occlusive coronary thrombus with local administration of abciximab during PTCA;Bartorelli;Catheter Cardiovasc Interv,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial experience with the coronary sinus reducer for the treatment of refractory angina in Spain;Revista Española de Cardiología (English Edition);2023-05

2. Liquid Drug Delivery Approaches for the Treatment of Occlusive Arterial Disease: A Systematic Review;Journal of Endovascular Therapy;2022-09-01

3. Eptifibatida y vasodilatadores intracoronarios para prevenir la ausencia de reperfusión en el IAMCEST con diabetes y alta carga de trombos. Un ensayo aleatorizado;Revista Española de Cardiología;2022-09

4. Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial;Revista Española de Cardiología (English Edition);2022-09

5. Cardioprotective Effect of Acetylsalicylic Acid in the Myocardial Ischemia-Reperfusion Model on Oxidative Stress Markers Levels in Heart Muscle and Serum;Antioxidants;2022-07-23